EMC, Jazz Pharma: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Amyris ( AMRS) upgraded at Morgan Stanley from Equal-weight to Overweight. $32 price target. Company continues to execute on its growth strategy.

Cameron International ( CAM) upgraded at Credit Suisse from Neutral to Outperform. $73 price target. Very strong orders.

EMC ( EMC) upgraded at Oppenheimer from Perform to Outperform. $32 price target. Stock is attractive, following a recent pullback.

East West Bancorp ( EWBC) upgraded at FBR from Market Perform to Outperform. $23 price target. Stock is attractively valued, following a recent pullback.

Exelon ( EXC) upgraded at UBS from Neutral to Buy. $50 price target. Cost synergy story and leverage to power recovery.

Jazz Pharmaceuticals ( JAZZ) upgraded at Jefferies to Buy. $52 price target. Estimates also upped, given recent Xyrem growth.

Oceaneering International ( OII) downgraded at Credit Suisse from Outperform to Neutral. $48 price target. Central theses played out.

Oil States ( OIS) upgraded at Credit Suisse from Neutral to Outperform. $110 price target. Stock should continue to deliver higher earnings.

Rockwell Automation ( ROK) upgraded at Baird from Neutral to Outperform. $92 price target. Company can continue to deliver solid growth over the coming years.

RadioShack ( RSH) upgraded at Goldman from Neutral to Buy. Company was also added to the Conviction Buy list. $18 price target. Company is improving its position in the wireless market.

Vanguard Health ( VHS) rated new Overweight at JP Morgan. $22 price target. Company has attractive exposure to urban markets.

Vodafone ( VOD) upgraded at UBS from Neutral to Buy. $31.05 price target. VZW dividend larger than expected.

Vertex Pharmaceuticals ( VRTX) upgraded at Citigroup from Hold to Buy. $60 price target. Incivek should not disappoint.

End of report.

This article was written by a staff member of TheStreet.

More from Stocks

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

Dow Trades Above 25,000 as U.S.-China Trade Tensions Thaw

Dow Trades Above 25,000 as U.S.-China Trade Tensions Thaw

GE's $11.1 Billion Deal With Wabtec Should Have Warren Buffett Feeling Very Sad

GE's $11.1 Billion Deal With Wabtec Should Have Warren Buffett Feeling Very Sad

How to Trade Apple Ahead of Alphabet's Launch of YouTube Music

How to Trade Apple Ahead of Alphabet's Launch of YouTube Music

18 Top Stocks Hedge Funds Own That Goldman Sachs Thinks Will Keep Outperforming

18 Top Stocks Hedge Funds Own That Goldman Sachs Thinks Will Keep Outperforming